NAB1 encodes a transcriptional repressor that inhibits the zinc finger transcription factors EGR1 and EGR2, which are important for nervous system development. Mutations cause autosomal dominant or recessive neurodevelopmental disorders with intellectual disability, developmental delay, and various neurological features. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.59), consistent with its role in essential developmental processes.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.59
Clinical SummaryNAB1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.31) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.59LOEUF
pLI 0.022
Z-score 3.00
OE 0.31 (0.180.59)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.35Z-score
OE missense 0.76 (0.680.86)
194 obs / 254.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.31 (0.180.59)
00.351.4
Missense OE0.76 (0.680.86)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 7 / 22.3Missense obs/exp: 194 / 254.6Syn Z: 0.45

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NAB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →